Published by Benjamin Chiou on 12th December 2025
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
URL: http://www.digitallook.com/dl/news/story/35559983/...